Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-24
SponsorUniversity of Pittsburgh

About this trial

The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking participants aged 16-24 years who were diagnosed with type 2 diabetes before age 18. Participants will be asked to fill out surveys about diabetes, physical activity, and diet before and after wearing a CGM for 30 days. At the end of wearing the CGM, participants will complete an interview about their experience.

Eligibility criteria

Qualifiers

Ages 16-24 years, any sex or gender

Diagnosis of type 2 diabetes in childhood (younger than 18 years of age)

English-speaking (app in English)

Possession of personal smartphone that is compatible with FreeStyle Libre app

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Healthmine app

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Pittsburgh

Lead sponsor

San Diego State University

Collaborator

Emory University

Collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

University of Michigan

Collaborator

Dartmouth College

Collaborator